AIkido Pharma Inc. – NASDAQ:AIKI
AIkido Pharma stock price monthly change
AIkido Pharma stock price quarterly change
AIkido Pharma stock price yearly change
AIkido Pharma key metrics
Market Cap | 19.52M |
Enterprise value | N/A |
P/E | -1.14 |
EV/Sales | N/A |
EV/EBITDA | 0.91 |
Price/Sales | N/A |
Price/Book | 0.23 |
PEG ratio | -0.02 |
EPS | -3.94 |
Revenue | N/A |
EBITDA | -20.72M |
Income | -20.08M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAIkido Pharma stock price history
AIkido Pharma stock forecast
AIkido Pharma financial statements
| Dec 2022 | 0 | -4.19M | |
|---|---|---|---|
| Mar 2023 | 0 | -3.69M | |
| Jun 2023 | 71K | -8.66M | -12201.41% |
| Sep 2023 | 963K | -3.54M | -367.71% |
| 2022-05-16 | -0.34 | -0.68 |
|---|---|---|
| 2022-08-12 | -0.68 | -1.18 |
| 2022-11-17 | -0.77 | -1.17 |
| Dec 2022 | 76236000 | 2.46M | 3.24% |
|---|---|---|---|
| Mar 2023 | 74154000 | 5.08M | 6.85% |
| Jun 2023 | 67695000 | 5.91M | 8.74% |
| Sep 2023 | 63206000 | 4.85M | 7.69% |
| Dec 2022 | -1.86M | 1.36M | -821K |
|---|---|---|---|
| Mar 2023 | -3.99M | -18.71M | -939K |
| Jun 2023 | -6.84M | 0 | 0 |
| Sep 2023 | -3.54M | 0 | 0 |
AIkido Pharma alternative data
| Aug 2023 | 4 |
|---|---|
| Sep 2023 | 4 |
| Oct 2023 | 4 |
| Nov 2023 | 4 |
| Dec 2023 | 4 |
| Jan 2024 | 4 |
| Feb 2024 | 4 |
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 4 |
| Jun 2024 | 4 |
| Jul 2024 | 4 |
AIkido Pharma other data
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 80000 | 0 |
| Apr 2023 | 35698 | 0 |
| May 2023 | 14000 | 0 |
| Jun 2023 | 3749 | 0 |
| Aug 2023 | 10369 | 0 |
| Sep 2023 | 38000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | WOOL KYLE MICHAEL director | Common Stock | 5,000 | $2.77 | $13,835 | ||
Purchase | HAYES ANTHONY director, officer.. | Common Stock | 5,000 | $2.74 | $13,715 | ||
Purchase | HAYES ANTHONY director, officer.. | Common Stock | 2,500 | $2.58 | $6,438 | ||
Purchase | HAYES ANTHONY director, officer.. | Common Stock | 7,500 | $2.5 | $18,750 | ||
Purchase | WOOL KYLE MICHAEL director | Common Stock | 2,500 | $2.66 | $6,657 | ||
Purchase | WOOL KYLE MICHAEL director | Common Stock | 7,400 | $2.5 | $18,522 | ||
Purchase | WOOL KYLE MICHAEL director | Common Stock | 100 | $2.53 | $253 | ||
Purchase | WOOL KYLE MICHAEL director | Common Stock | 2,000 | $2.55 | $5,092 | ||
Purchase | WOOL KYLE MICHAEL director | Common Stock | 2,000 | $2.74 | $5,470 | ||
Purchase | HAYES ANTHONY director, officer.. | Common Stock | 2,000 | $2.75 | $5,494 |
-
When is AIkido Pharma's next earnings date?
Unfortunately, AIkido Pharma's (AIKI) next earnings date is currently unknown.
-
Does AIkido Pharma pay dividends?
No, AIkido Pharma does not pay dividends.
-
How much money does AIkido Pharma make?
AIkido Pharma has a market capitalization of 19.52M. AIkido Pharma made a loss 29.87M US dollars in net income (profit) last year or -$1.17 on an earnings per share basis.
-
What is AIkido Pharma's stock symbol?
AIkido Pharma Inc. is traded on the NASDAQ under the ticker symbol "AIKI".
-
What is AIkido Pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of AIkido Pharma?
Shares of AIkido Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are AIkido Pharma's key executives?
AIkido Pharma's management team includes the following people:
- Mr. Anthony C. Hayes Esq. Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer & Director(age: 57, pay: $1,100,000)
-
How many employees does AIkido Pharma have?
As Jul 2024, AIkido Pharma employs 4 workers.
-
When AIkido Pharma went public?
AIkido Pharma Inc. is publicly traded company for more then 45 years since IPO on 18 Mar 1980.
-
What is AIkido Pharma's official website?
The official website for AIkido Pharma is aikidopharma.com.
-
Where are AIkido Pharma's headquarters?
AIkido Pharma is headquartered at ONE ROCKEFELLER PLAZA, 11TH FLOOR, New York City, NEW YORK.
-
How can i contact AIkido Pharma?
AIkido Pharma's mailing address is ONE ROCKEFELLER PLAZA, 11TH FLOOR, New York City, NEW YORK and company can be reached via phone at +1 347 321 7646.
AIkido Pharma company profile:
AIkido Pharma Inc.
aikidopharma.comNASDAQ
4
Biotechnology
Healthcare
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.
New York City, NEW YORK 10020
CIK: 0000012239
ISIN: US0088751062
CUSIP: 008875106
